Who
William H. Carson
Director
Company insider
Files Form 4 as: Director, Annexon; Director, Decibel Therapeutics; Director, Prevail Therapeutics.
In numbers
- Trades disclosed
- 40
- Buys
- 18
- Sells
- 0
- Bought
- $536K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 9 Sep 2020
- Last trade
- 11 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 15 Jun 2026 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 11 May 2026filed 13 May 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $46K8,000 at $5.78 | filing |
| 11 May 2026filed 13 May 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $46K8,000 at $5.78 | filing |
| 10 Apr 2026filed 14 Apr 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $50K8,000 at $6.20 | filing |
| 10 Apr 2026filed 14 Apr 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $50K8,000 at $6.20 | filing |
| 10 Mar 2026filed 12 Mar 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $45K8,000 at $5.67 | filing |
| 10 Mar 2026filed 12 Mar 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $45K8,000 at $5.67 | filing |
| 30 Dec 2025filed 2 Jan 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $21K4,115 at $5.02 | filing |
| 30 Dec 2025filed 2 Jan 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $21K4,115 at $5.02 | filing |
| 1 Dec 2025filed 3 Dec 2025 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $18K4,115 at $4.47 | filing |
| 30 Oct 2025filed 31 Oct 2025 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $13K4,115 at $3.17 | filing |
| 30 Sep 2025filed 2 Oct 2025 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $13K4,115 at $3.05 | filing |
| 2 Sep 2025filed 4 Sep 2025 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $8,6004,115 at $2.09 | filing |
| 30 Jul 2025filed 1 Aug 2025 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $9,9994,115 at $2.43 | filing |
| 30 Jun 2025filed 1 Jul 2025 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $10K4,115 at $2.46 | filing |
| 5 Jun 2025filed 9 Jun 2025 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 2 Dec 2024filed 4 Dec 2024 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $17K3,200 at $5.33 | filing |
| 1 Oct 2024filed 2 Oct 2024 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $19K3,200 at $5.97 | filing |
| 3 Sep 2024filed 4 Sep 2024 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $18K3,200 at $5.48 | filing |
News
No headline names them, or the companies they trade most, lately.